(Q41571903)

3 October 2017

0 references

Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections (English)

1 reference

14-alpha sterol demethylase

3 October 2017

1 reference

6 February 2019

1 reference

1 reference

Natalie K Boyd

1

1 reference

3 October 2017

Cindy L Zoellner

series ordinal

2

1 reference

3 October 2017

Mark A Swancutt

series ordinal

3

1 reference

3 October 2017

Kavita P Bhavan

series ordinal

4

1 reference

3 October 2017

language of work or name

English

0 references

publication date

13 August 2012

1 reference

Antimicrobial Agents and Chemotherapy

3 October 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 October 2017

56

1 reference

3 October 2017

11

1 reference

3 October 2017

6001-6002

1 reference

Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients

3 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Voriconazole therapeutic drug monitoring.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3486541

Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22890768

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22890768

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00700-12

1 reference

3 October 2017

1 reference

3 October 2017

1 reference